Premium
Combination treatments for overactive bladder refractory to first‐line pharmacotherapy: do they meet expectations?
Author(s) -
Apostolidis Apostolos
Publication year - 2017
Publication title -
bju international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.773
H-Index - 148
eISSN - 1464-410X
pISSN - 1464-4096
DOI - 10.1111/bju.13988
Subject(s) - solifenacin , mirabegron , overactive bladder , medicine , urology , combination therapy , alternative medicine , pathology